Insider Transactions in Q4 2024 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
79,246
-44.02%
|
$2,535,872
$32.32 P/Share
|
|
Dec 17
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
10,012
-57.77%
|
$320,384
$32.2 P/Share
|
|
Dec 17
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
25,550
-11.66%
|
$817,600
$32.2 P/Share
|
|
Dec 16
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
78,127
-14.13%
|
$2,265,683
$29.2 P/Share
|
|
Dec 16
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,335
+15.0%
|
$150,670
$2.43 P/Share
|
|
Dec 16
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-4.25%
|
$1,378,486
$29.34 P/Share
|
|
Dec 16
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
472
-2.65%
|
$13,688
$29.58 P/Share
|
|
Dec 16
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
472
+2.58%
|
$4,248
$9.41 P/Share
|
|
Dec 13
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
97,062
-46.26%
|
$2,911,860
$30.02 P/Share
|
|
Dec 13
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
176,308
+45.66%
|
-
|
|
Dec 13
2024
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,778
-4.09%
|
$863,340
$30.02 P/Share
|
|
Dec 13
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,146
+9.41%
|
-
|
|
Dec 13
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
51,573
-25.39%
|
$1,547,190
$30.02 P/Share
|
|
Dec 13
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
93,718
+31.57%
|
-
|
|
Dec 13
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,751
-11.39%
|
$712,530
$30.02 P/Share
|
|
Dec 13
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,209
+17.17%
|
-
|
|
Dec 13
2024
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,387
-2.63%
|
$161,610
$30.02 P/Share
|
|
Dec 13
2024
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,988
+5.95%
|
-
|
|
Dec 13
2024
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,875
-40.66%
|
$356,250
$30.02 P/Share
|
|
Dec 13
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,090
+45.2%
|
-
|
|
Dec 13
2024
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,046
+5.7%
|
-
|
|
Dec 13
2024
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,304
-16.18%
|
$1,269,120
$30.02 P/Share
|
|
Dec 13
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
76,508
+22.64%
|
-
|
|
Dec 10
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
85,561
-4.12%
|
$2,652,391
$31.21 P/Share
|
|
Dec 10
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
85,561
+10.67%
|
$0
$0.4 P/Share
|
|
Dec 10
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,259
-3.78%
|
$232,288
$32.25 P/Share
|
|
Dec 10
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,259
+3.64%
|
$43,554
$6.82 P/Share
|
|
Dec 02
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
33,513
-50.01%
|
$1,105,929
$33.38 P/Share
|
|
Dec 02
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,054
-1.1%
|
$67,782
$33.56 P/Share
|
|
Dec 02
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,054
+1.09%
|
$22,594
$11.53 P/Share
|
|
Nov 26
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,343
-1.4%
|
$67,947
$29.9 P/Share
|
|
Nov 25
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,303
-8.56%
|
$449,878
$26.49 P/Share
|
|
Nov 25
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,303
+7.92%
|
$86,515
$5.01 P/Share
|
|
Nov 25
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
101,993
-12.7%
|
$2,753,811
$27.46 P/Share
|
|
Nov 25
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
97,776
+31.77%
|
$488,880
$5.01 P/Share
|
|
Nov 19
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-3.92%
|
$165,000
$22.0 P/Share
|
|
Nov 19
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.77%
|
$97,500
$13.9 P/Share
|
|
Nov 18
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
472
-8.45%
|
$8,968
$19.42 P/Share
|
|
Nov 18
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
472
+7.79%
|
$4,248
$9.41 P/Share
|
|
Nov 18
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
58,750
-2.2%
|
$1,175,000
$20.92 P/Share
|
|
Nov 18
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,750
+7.86%
|
$0
$0.4 P/Share
|
|
Nov 14
2024
|
Anja Manuel Director |
BUY
Open market or private purchase
|
Direct |
1,000
+16.67%
|
$24,000
$24.5 P/Share
|
|
Nov 13
2024
|
David B Wells Director |
SELL
Open market or private sale
|
Direct |
40,000
-20.4%
|
$1,160,000
$29.99 P/Share
|
|
Nov 13
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
142,886
-14.63%
|
$4,000,808
$28.98 P/Share
|
|
Nov 13
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
109,309
+18.89%
|
$874,472
$8.27 P/Share
|
|
Nov 12
2024
|
Anja Manuel Director |
BUY
Open market or private purchase
|
Direct |
4,000
+50.0%
|
$104,000
$26.94 P/Share
|
|
Nov 12
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,338
-1.38%
|
$60,788
$26.46 P/Share
|
|
Nov 11
2024
|
Michael Chi Chief Commercial Officer |
SELL
Bona fide gift
|
Direct |
10,000
-5.16%
|
-
|
|
Nov 11
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,259
-3.61%
|
$174,216
$24.77 P/Share
|
|
Nov 11
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,259
+3.48%
|
$43,554
$6.82 P/Share
|